The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Krasnopolskaya K.V.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii;
kafedra akusherstva i ginekologii FUV MONIKI im. M.F. Vladimirskogo

Nazarenko T.A.

Kafedra akusherstva, ginekologii, perinatologii i reproduktologii fakul'teta poslediplomnogo professional'nogo obucheniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova;
Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova

Beketova A.N.

Moscow Regional Research Institute of Obstetrics and Gynecology, Ministry of Health of the Moscow Region, Moscow, Russia;
International Clinic «Family», Moscow, Russia

Ivakhnenko V.N.

Otdelenie reproduktsii Moskovskogo oblastnogo NII akusherstva i ginekologii

Kabanova D.I.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Lh-containing recombinant and urinary gonadotropins in the prevention of poor ovarian response in ivf-et

Authors:

Krasnopolskaya K.V., Nazarenko T.A., Beketova A.N., Ivakhnenko V.N., Kabanova D.I.

More about the authors

Journal: Russian Journal of Human Reproduction. 2013;(4): 67‑70

Read: 1152 times

Download PDF (RU)
Contact the author
Table of contents

LH-CONTAINING RECOMBINANT AND URINARY GONADOTROPINS IN THE PREVENTION OF POOR OVARIAN RESPONSE IN IVF-ET
LH-CONTAINING RECOMBINANT AND URINARY GONADOTROPINS IN THE PREVENTION OF POOR OVARIAN RESPONSE IN IVF-ET

To cite this article:

Krasnopolskaya KV, Nazarenko TA, Beketova AN, Ivakhnenko VN, Kabanova DI. Lh-containing recombinant and urinary gonadotropins in the prevention of poor ovarian response in ivf-et. Russian Journal of Human Reproduction. 2013;(4):67‑70. (In Russ.)

Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Age-related pecu­liarities of blood para­meters in women and their impact on the outcome of in vitro fertilization programs. Russian Journal of Human Reproduction. 2025;(2):28-36
Visualization of the mito­tic spindle in oocy­tes of patients with ovarian endo­metriosis as a prognostic factor for the effe­ctiveness of fertilization and early embryonic deve­lopment in IVF/ICSI programs. Russian Journal of Human Reproduction. 2025;(3):55-62
Influence of carriage of papi­llomavirus infe­ction on the course of exte­rnal geni­tal endo­metriosis in patients with intraepithelial lesion of the cervix. Russian Journal of Human Reproduction. 2025;(3):77-83
Expe­rimental mode­ling and treatment of endo­metriosis using bovhyaluronidase azoximer in an animal model. Russian Journal of Human Reproduction. 2025;(4):26-40
The Pate­rnity Test. Russian Journal of Human Reproduction. 2025;(4):41-45
Extracellular vesi­cles and their role in endo­metrial rece­ptivity in patients with recu­rrent implantation failure. Russian Journal of Human Reproduction. 2025;(4):46-52
Study of athrombogenic and thro­mbogenic factors of the endo­thelium in women with an unexpected poor and subo­ptimal ovarian response during the treatment of infe­rtility by methods of assi­sted reproductive technology. Russian Journal of Human Reproduction. 2025;(4):56-63
Primary ovarian insu­fficiency: oppo­rtunities and prospects for the realization of reproductive function. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):42-47
The role of pelvic inflammatory diseases in reproductive function diso­rders in women. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):48-54
Characteristics of factors contributing to diso­rders of reproductive function in patients with adenomyosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):68-74
Abstract:

The comparative data characterizing the ability of LH-containing preparations, urinary and recombinant gonadotrophins, to prevent suboptimal/poor response and their influence on IVF outcomes in women with prognosis of poor ovarian response are represented.

Keywords:

infertility
IVF
Menopur
Pergoveris

Authors:

Krasnopolskaya K.V.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii;
kafedra akusherstva i ginekologii FUV MONIKI im. M.F. Vladimirskogo

Nazarenko T.A.

Kafedra akusherstva, ginekologii, perinatologii i reproduktologii fakul'teta poslediplomnogo professional'nogo obucheniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova;
Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova

Beketova A.N.

Moscow Regional Research Institute of Obstetrics and Gynecology, Ministry of Health of the Moscow Region, Moscow, Russia;
International Clinic «Family», Moscow, Russia

Ivakhnenko V.N.

Otdelenie reproduktsii Moskovskogo oblastnogo NII akusherstva i ginekologii

Kabanova D.I.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Close metadata

References:

  1. Ferraretti A.P., Gianaroli L., Magli M. et al. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 2004; 82: 6: 1521-1526.
  2. Ferraretti A.P., Feliciani E., Tabanelli C. et al. LH pre-treatment as strategy for repeated young poor ovarian responders. Human Reprod 2012; 27: Suppl 1: 109-110.
  3. Bosch E., Labarta E., Crespo J. et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Human Reprod 2010; 25: 2092-2100.
  4. Bourgain C., Devroey P. The endometrium in stimulated cycles for IVF. Human Reprod Update 2003; 9: 515-522.
  5. Sharma V., Salha O., Dada T. et al. The outcome of assisted reproduction treatment cycles using urinary compared to recombinant gonadotropins. Human Reprod 2001; 16: Suppl 1: 134-135.
  6. Aflan M., Coomarasamy A., Van Wely M. et al. Statistically significant increase births with hMG in IVF and ICSI cycles versus rFSH: results from systematic review. Human Reprod 2007; 22: Suppl 1: 39.
  7. Karlström P.O., Rodriques-Wallberg K.A. Stimulation with hMG results in higher live birth and ongoing pregnancy rates than rFSH in IVF/ICSI patients requiring with high doses of gonadotropins. Human Reprod 2012; 27: Suppl 1: 227-228.
  8. Matorras R., Prieto B., Exposito A. et al. Mid-follicular LH supplementation in women 35-39 years undergoing ICSI cycles: a randomized controlled study. Reprod Biomed Online 2009; 19: 879-887.
  9. Ovarial'nyi rezerv: opredelenie, diagnostika i znachenie pri stimulyatsii funktsii yaichnikov. V kn.: Stimulyatsiya funktsii yaichnikov. Pod red. T.A. Nazarenko. M: MEDpress-inform 2009; 35-42.
  10. Mochtar M.H., Van der Veen F., Ziech M., van Wely M. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2007; 2:CD005070.
  11. Franco J.G., Baruffi R.L.R., Oliveira J.B.A. et al. Effects of recombinant LH supplementation to recombinant FSH in the GnRH-agonist protocol: a mach case-control study. Human Reprod 2009; 24: Suppl 1: 131-132.
  12. Ruiz Balda J.A., Caballero J.L., Roque A., Ezcurra D. Clinical experience with Pergoveris, a new formulation of rFSH and rLH in a 2:1 ratio, for treatment of suboptimal patient populations: Spanish preliminary results. Fertil Steri 2009; 92: Suppl: S163.
  13. Out H., Mannaeris B., Driessen S. et al. Recombinant FSH (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies. Human Reprod Update 1996; 2: 162-171.
  14. Teissier M.P., Chable H., Paulhac S., Aubard Y. Recombinant human follicle-stimulating hormone versus human menopausal gonadotropin induction: effects of mature follicle endocrinology. Human Reprod 1999; 14: 9: 2236-2241.
  15. Mamedova N.R., Nazarenko T.A., Monakhova I.V. Preparaty, soderzhashchie lyuteiniziruyushchii gormon, v programmakh EKO (obzor literatury). Probl reprod 2011; 17: 3: 50-55.
  16. Carone D., Vizziello G., Vitti A., Chiappetta R. Clinical outcomes of ovulation induction in WHO Group I anovulatory women using r-hFSH+rhLH in a 2:1 ratio compared to hMG. Human Reprod 2010; 25: Suppl 1: 312.
  17. Buhler K.F., Fisher R. Recombinant human LH supplementation versus supplementation with urinary hCG-based LH-activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case-control study. Gynecol Endocrinol 2012; 28: 5: 345-350.
  18. Podzolkova N.M., Koloda Yu.A. Preodolenie "bednogo" otveta v programmakh VRT: novye vozmozhnosti terapii. Probl reprod 2012; 18: 2: 77-82.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.